Researchers reported a DNA-guided CRISPR–Cas12a system that enables programmable RNA recognition and cleavage, expanding Cas12a beyond RNA-guided operation. The approach, described in a DNA-guided Cas12a architecture, uses synthetic CRISPR DNA to activate Cas12a while repurposing RNA as the target. The work details a molecular activation pathway distinct from canonical RNA-guided systems, supported by structural, biophysical, and biochemical analyses. The authors also report intracellular RNA knockdown capability, positioning the platform as a modular framework for programmable RNA manipulation. The advance matters for diagnostics and therapeutic RNA targeting because it adds a new design space for guide/effector pairing and could inform next-generation CRISPR-based detection and gene-silencing strategies.